The most recent work advances our understanding of the complex signaling pathways controlling allergic inflammation and paves the way for targeted manipulation of the IL-4/IL-13 pathway in the quest for additional therapeutic interventions against allergic diseases. The gene discussed is IL13; the disease is inflammation.